Stock ISCO INTERNATIONAL STEM CELL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News International Stem Cell Corporation

Equities

ISCO

US4603782016

Market Closed - OTC Markets
Other stock markets
 12:51:03 2024-04-17 pm EDT 		5-day change 1st Jan Change
0.0712 USD +0.14% Intraday chart for International Stem Cell Corporation -40.67% +14.84%
Mar. 28 International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
International Stem Cell Corporation and Dr. Andrey Semechkin Agrees to Extend (Until September 15, 2024) the Maturity Date of the Loan
CI
Bayer says Parkinson's stem cell therapy improves symptoms in initial trial
RE
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Bayer claims early lead in Parkinson's stem cell therapy
RE
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
INTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
International Stem Cell Corporation Auditor Raises 'Going Concern' Doubt
CI
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ISCO Stock
  4. News International Stem Cell Corporation